Caliper Life Sciences (CALP) Tops Q1 EPS by 3c, Posts Q2 and FY11 Revenue Guidance
Tweet
Share
E-mailGet Alerts CALP Hot Sheet
Price: $10.49 --0%
Financial Fact:
Cost of product revenue: 12.53M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of product revenue: 12.53M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Caliper Life Sciences (NASDAQ: CALP) reported Q1 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $35.8 million versus the consensus estimate of $33.46 million.
Caliper Life Sciences sees FY2011 GAAP revenue of $138-$146 million, versus the consensus of $141.3 million.
Caliper Life Sciences sees Q2 2011 GAAP revenue of $33-$36 million, versus the consensus of $33.96 million.
Caliper Life Sciences sees FY2011 GAAP revenue of $138-$146 million, versus the consensus of $141.3 million.
Caliper Life Sciences sees Q2 2011 GAAP revenue of $33-$36 million, versus the consensus of $33.96 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
